{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:09:38Z","timestamp":1783742978970,"version":"3.55.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.tripleo.2011.04.020","type":"journal-article","created":{"date-parts":[[2011,8,8]],"date-time":"2011-08-08T21:19:43Z","timestamp":1312838383000},"page":"744-753","source":"Crossref","is-referenced-by-count":58,"title":["A model for the pathogenesis of bisphosphonate-associated osteonecrosis of the jaw and teriparatide's potential role in its resolution"],"prefix":"10.1016","volume":"112","author":[{"given":"Gayathri","family":"Subramanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold V.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Y.P.","family":"Quek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tripleo.2011.04.020_bib1","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1126\/science.305.5689.1420","article-title":"Coming to grips with bone loss","volume":"305","author":"Marx","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.tripleo.2011.04.020_bib2","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.04.020_bib3","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.04.020_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","article-title":"Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia","volume":"65","author":"Mavrokokki","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.04.020_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.14219\/jada.archive.2009.0019","article-title":"Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry","volume":"140","author":"Sedghizadeh","year":"2009","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.tripleo.2011.04.020_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/BOR.0b013e32832ca433","article-title":"Osteoporosis treatments and adverse events","volume":"21","author":"Solomon","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.tripleo.2011.04.020_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1747-4477.2009.00213.x","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw\u20142009 update","volume":"35","author":"Ruggiero","year":"2009","journal-title":"Aust Endod J"},{"key":"10.1016\/j.tripleo.2011.04.020_bib8","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.04.020_bib9","first-page":"115","article-title":"Oral bisphosphonate therapy and osteonecrosis of the jaw: what to tell the concerned patient","volume":"20","author":"Koka","year":"2007","journal-title":"Int J Prosthodont"},{"key":"10.1016\/j.tripleo.2011.04.020_bib10","first-page":"2","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.04.020_bib11","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMc1002684","article-title":"Teriparatide therapy for alendronate-associated osteonecrosis of the jaw","volume":"363","author":"Cheung","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2011.04.020_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.joms.2006.10.076","article-title":"Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]","volume":"65","author":"Harper","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.04.020_bib13","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3899\/jrheum.081176","article-title":"Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapy","volume":"36","author":"Lau","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.tripleo.2011.04.020_bib14","article-title":"Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy","author":"Lee","year":"2010","journal-title":"Head Neck"},{"key":"10.1016\/j.tripleo.2011.04.020_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1754-4505.2009.00128.x","article-title":"Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report","volume":"30","author":"Narongroeknawin","year":"2010","journal-title":"Spec Care Dentist"},{"key":"10.1016\/j.tripleo.2011.04.020_bib16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3899\/jrheum.091022","article-title":"More on the resolution of bisphosphonate-associated osteonecrosis of the jaw","volume":"37","author":"Tsai","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.tripleo.2011.04.020_bib17","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00198-009-0859-4","article-title":"Bone microdamage","volume":"20","author":"Chapurlat","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.tripleo.2011.04.020_bib18","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00198-009-0899-9","article-title":"Bone microdamage: a clinical perspective","volume":"20","author":"Chapurlat","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.tripleo.2011.04.020_bib19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MNH.0b013e32832b75f1","article-title":"Cross-talk among bone cells","volume":"18","author":"Matsuo","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.tripleo.2011.04.020_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.abb.2008.03.027","article-title":"Osteoclast-osteoblast communication","volume":"473","author":"Matsuo","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.tripleo.2011.04.020_bib21","doi-asserted-by":"crossref","first-page":"25103","DOI":"10.1074\/jbc.R109.041087","article-title":"Cellular and molecular mechanisms of bone remodeling","volume":"285","author":"Raggatt","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tripleo.2011.04.020_bib22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.semcdb.2008.07.016","article-title":"Bone remodeling: multiple cellular interactions required for coupling of bone formation and resorption","volume":"19","author":"Sims","year":"2008","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.tripleo.2011.04.020_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.22203\/eCM.v006a05","article-title":"Bone microdamage and cell apoptosis","volume":"6","author":"Noble","year":"2003","journal-title":"Eur Cells Mater"},{"key":"10.1016\/j.tripleo.2011.04.020_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/09243860500096248","article-title":"Microdamage and apoptosis","volume":"42","author":"Noble","year":"2005","journal-title":"Eur J Morphol"},{"key":"10.1016\/j.tripleo.2011.04.020_bib25","doi-asserted-by":"crossref","first-page":"C934","DOI":"10.1152\/ajpcell.00234.2002","article-title":"Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone","volume":"284","author":"Noble","year":"2003","journal-title":"Am J Physiol, Cell Physiol"},{"key":"10.1016\/j.tripleo.2011.04.020_bib26","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s00198-010-1194-5","article-title":"Osteocyte: the unrecognized side of bone tissue","volume":"21","author":"Rochefort","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.tripleo.2011.04.020_bib27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1615\/CritRevEukarGeneExpr.v19.i3.40","article-title":"Bone modeling and remodeling","volume":"19","author":"Seeman","year":"2009","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.tripleo.2011.04.020_bib28","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s00198-006-0220-0","article-title":"Osteocytes\u2014martyrs for integrity of bone strength","volume":"17","author":"Seeman","year":"2006","journal-title":"Osteoporos Int"},{"issue":"Suppl 7","key":"10.1016\/j.tripleo.2011.04.020_bib29","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2009.0080","article-title":"The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumors","volume":"7","author":"Lipton","year":"2009","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.tripleo.2011.04.020_bib30","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","article-title":"Pathogenesis of osteoporosis: concepts, conflicts, and prospects","volume":"115","author":"Raisz","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tripleo.2011.04.020_bib31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mce.2009.06.002","article-title":"Is Wnt signalling the final common pathway leading to bone formation?","volume":"310","author":"Milat","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.tripleo.2011.04.020_bib32","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1210\/jc.2010-0856","article-title":"Update on estrogens and the skeleton","volume":"95","author":"Khosla","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.tripleo.2011.04.020_bib33","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar2165","article-title":"Biology of RANK, RANKL, and osteoprotegerin","volume":"9","author":"Boyce","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.tripleo.2011.04.020_bib34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00439-009-0773-z","article-title":"Genetics of osteoporosis: accelerating pace in gene identification and validation","volume":"127","author":"Li","year":"2010","journal-title":"Hum Genet"},{"key":"10.1016\/j.tripleo.2011.04.020_bib35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids","volume":"102","author":"Weinstein","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tripleo.2011.04.020_bib36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.lfs.2009.09.009","article-title":"Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss","volume":"85","author":"Wang","year":"2009","journal-title":"Life Sci"},{"key":"10.1016\/j.tripleo.2011.04.020_bib37","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00198-004-1780-5","article-title":"Assessment of fracture risk","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.tripleo.2011.04.020_bib38","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1080\/1042819031000082966","article-title":"New insights in myeloma-induced osteolysis","volume":"44","author":"Barille-Nion","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.tripleo.2011.04.020_bib39","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1172\/JCI115305","article-title":"Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma","volume":"88","author":"Bataille","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tripleo.2011.04.020_bib40","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/leu.2008.336","article-title":"Pathogenesis of myeloma bone disease","volume":"23","author":"Roodman","year":"2009","journal-title":"Leukemia"},{"issue":"Suppl 1","key":"10.1016\/j.tripleo.2011.04.020_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/10245330512331389782","article-title":"Myeloma bone disease","volume":"10","author":"Sezer","year":"2005","journal-title":"Hematology"},{"key":"10.1016\/j.tripleo.2011.04.020_bib42","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1365-2141.2002.03257.x","article-title":"Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity","volume":"116","author":"Yaccoby","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tripleo.2011.04.020_bib43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1517\/14728220903525720","article-title":"Dickkopf-1 as a potential therapeutic target in Paget's disease of bone","volume":"14","author":"McCarthy","year":"2010","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.tripleo.2011.04.020_bib44","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.clinbiochem.2009.04.007","article-title":"Increased circulating Dickkopf-1 in Paget's disease of bone","volume":"42","author":"Marshall","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1016\/j.tripleo.2011.04.020_bib45","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.tripleo.2011.04.020_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/mi.10.3.5","article-title":"Bisphosphonate therapeutics in bone disease: the hard and soft data on osteoclast inhibition","volume":"10","author":"Drake","year":"2010","journal-title":"Mol Interv"},{"key":"10.1016\/j.tripleo.2011.04.020_bib47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1742-1241.2008.01911.x","article-title":"Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club","volume":"63","author":"Bergmann","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.tripleo.2011.04.020_bib48","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ncponc1323","article-title":"Effect of bisphosphonates on pain and quality of life in patients with bone metastases","volume":"6","author":"Costa","year":"2009","journal-title":"Nat Clin Pract Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.tripleo.2011.04.020_bib49","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.breast.2007.10.005","article-title":"Bisphosphonates: reducing the risk of skeletal complications from bone metastasis","volume":"16","author":"Costa","year":"2007","journal-title":"Breast"},{"key":"10.1016\/j.tripleo.2011.04.020_bib50","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bone.2008.05.019","article-title":"Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling","volume":"43","author":"McDonald","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.tripleo.2011.04.020_bib51","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1007\/s10856-010-4154-x","article-title":"Surface immobilized zoledronate improves screw fixation in rat bone: a new method for the coating of metal implants","volume":"21","author":"Andersson","year":"2010","journal-title":"J Mater Sci Mater Med"},{"key":"10.1016\/j.tripleo.2011.04.020_bib52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cmet.2006.05.012","article-title":"Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis","volume":"4","author":"Zhao","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.tripleo.2011.04.020_bib53","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s002230010036","article-title":"Bisphosphonate treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage","volume":"69","author":"Li","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.tripleo.2011.04.020_bib54","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.mehy.2010.10.036","article-title":"Angiogenic suppression of osteoclasts may play a role in developing bisphosphonate-related osteonecrosis of the jaw","volume":"76","author":"Yin","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.tripleo.2011.04.020_bib55","first-page":"6538","article-title":"Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats","volume":"62","author":"Fournier","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.tripleo.2011.04.020_bib56","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0501.2010.01965.x","article-title":"Retrospective study of two biochemical markers for the risk assessment of oral bisphosphonate-related osteonecrosis of the jaws: can they be utilized as risk markers?","volume":"22","author":"Kwon","year":"2011","journal-title":"Clin Oral Implants Res"},{"key":"10.1016\/j.tripleo.2011.04.020_bib57","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra067395","article-title":"Mechanisms of anabolic therapies for osteoporosis","volume":"357","author":"Canalis","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tripleo.2011.04.020_bib58","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1172\/JCI33612","article-title":"Building bone to reverse osteoporosis and repair fractures","volume":"118","author":"Khosla","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tripleo.2011.04.020_bib59","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.2165\/00003495-200565170-00005","article-title":"Parathyroid hormone as an anabolic skeletal therapy","volume":"65","author":"Rubin","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.tripleo.2011.04.020_bib60","first-page":"41","article-title":"Parathyroid hormone as an anabolic therapy for women and men","volume":"28","author":"Bilezikian","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.tripleo.2011.04.020_bib61","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.bone.2009.12.032","article-title":"Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate","volume":"46","author":"Burshell","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.tripleo.2011.04.020_bib62","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.bone.2009.12.021","article-title":"Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate","volume":"46","author":"Eastell","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.tripleo.2011.04.020_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-010-0465-9","article-title":"Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm","volume":"68","author":"Vilardaga","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.tripleo.2011.04.020_bib64","doi-asserted-by":"crossref","first-page":"77S","DOI":"10.1016\/8756-3282(95)00183-E","article-title":"Osteoblast and chondroblast differentiation","volume":"17","author":"Aubin","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.tripleo.2011.04.020_bib65","first-page":"53","article-title":"Anabolic therapy for osteoporosis","volume":"50","author":"Bilezikian","year":"2005","journal-title":"Int J Fertil Womens Med"},{"key":"10.1016\/j.tripleo.2011.04.020_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-010-9360-5","article-title":"Parathyroid hormone and bone healing","volume":"87","author":"Ellegaard","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.tripleo.2011.04.020_bib67","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bone.2007.03.017","article-title":"Molecular and cellular mechanisms of the anabolic effect of intermittent PTH","volume":"40","author":"Jilka","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.tripleo.2011.04.020_bib68","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1210\/endo.142.9.8356","article-title":"Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation","volume":"142","author":"Ma","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.tripleo.2011.04.020_bib69","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1007\/s00018-010-0479-3","article-title":"Cellular communications in bone homeostasis and repair","volume":"67","author":"Nakahama","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.tripleo.2011.04.020_bib70","first-page":"16","article-title":"Glucocorticoid-induced osteoporosis and parathyroid hormone","volume":"33","author":"Carpinteri","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.tripleo.2011.04.020_bib71","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/IJWH.S4919","article-title":"Profile of teriparatide in the management of postmenopausal osteoporosis","volume":"2","author":"Sikon","year":"2010","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.tripleo.2011.04.020_bib72","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2147\/TCRM.S7776","article-title":"Role of teriparatide in treatment of glucocorticoid-induced osteoporosis","volume":"6","author":"Lau","year":"2010","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.tripleo.2011.04.020_bib73","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/jbmr.238","article-title":"Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis","volume":"26","author":"Cosman","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.tripleo.2011.04.020_bib74","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","article-title":"Osteonecrosis of the jaws in patients treated with bisphosphonates\u2014histomorphologic analysis in comparison with infected osteoradionecrosis","volume":"35","author":"Hansen","year":"2006","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.tripleo.2011.04.020_bib75","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2967\/jnumed.107.048785","article-title":"Bone scintigraphy and SPECT\/CT of bisphosphonate-induced osteonecrosis of the jaw","volume":"50","author":"Dore","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.tripleo.2011.04.020_bib76","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1158\/1078-0432.CCR-07-1430","article-title":"Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw","volume":"14","author":"Raje","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.tripleo.2011.04.020_bib77","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2967\/jnumed.109.064634","article-title":"Bone Scintigraphy and SPECT\/CT in bisphosphonate-induced osteonecrosis of the Jaw","volume":"50","author":"Dore","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.tripleo.2011.04.020_bib78","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00784-009-0300-6","article-title":"Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings","volume":"14","author":"Hoefert","year":"2010","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.tripleo.2011.04.020_bib79","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00784-009-0336-7","article-title":"Studying the role of microcracks in the pathophysiology of BRONJ","volume":"13","author":"Allen","year":"2009","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.tripleo.2011.04.020_bib80","doi-asserted-by":"crossref","first-page":"273S","DOI":"10.1016\/8756-3282(95)00303-U","article-title":"A histomorphometric study on effects of single and concurrent intermittent administration of human PTH (1-34) and bisphosphonate cimadronate on tibial metaphysis in ovariectomized rats","volume":"17","author":"Mashiba","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.tripleo.2011.04.020_bib81","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/RLU.0b013e3181feeb72","article-title":"Prognostic value of bone scintigraphy in cancer patients with osteonecrosis of the jaw","volume":"36","author":"Van den Wyngaert","year":"2010","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.tripleo.2011.04.020_bib82","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1302\/0301-620X.47B4.749","article-title":"A histological study of avascular necrosis of the femoral head after transcervical fracture","volume":"47","author":"Catto","year":"1965","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.tripleo.2011.04.020_bib83","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1634\/theoncologist.2009-0115","article-title":"Bisphosphonates and time to osteonecrosis development","volume":"14","author":"Palaska","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.tripleo.2011.04.020_bib84","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.joms.2009.12.030","article-title":"Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw\u2014a serial case analysis","volume":"68","author":"Chiu","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.04.020_bib85","doi-asserted-by":"crossref","first-page":"206132","DOI":"10.1155\/2010\/206132","article-title":"Short-term bisphosphonate therapy could ameliorate osteonecrosis: a complication in childhood hematologic malignancies","volume":"2010","author":"Greggio","year":"2010","journal-title":"Case Report Med"},{"key":"10.1016\/j.tripleo.2011.04.020_bib86","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/pbc.22428","article-title":"Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL)","volume":"54","author":"Kotecha","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.tripleo.2011.04.020_bib87","first-page":"766","article-title":"A review of bone pain relief with ibandronate and other bisphosphonates in disorders of increased bone turnover","volume":"25","author":"Ringe","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.tripleo.2011.04.020_bib88","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s00198-005-2001-6","article-title":"Effective and rapid treatment of painful localized transient osteoporosis (bone marrow edema) with intravenous ibandronate","volume":"16","author":"Ringe","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.tripleo.2011.04.020_bib89","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00520-008-0487-0","article-title":"Metastatic bone pain: treatment options with an emphasis on bisphosphonates","volume":"16","author":"von Moos","year":"2008","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.tripleo.2011.04.020_bib90","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bjoms.2009.08.030","article-title":"Osteonecrosis of the jaws induced by anti-RANK ligand therapy","volume":"48","author":"Taylor","year":"2010","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.04.020_bib91","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00405-011-1496-z","article-title":"Bisphosphonate-induced osteonecrosis of the external ear canal: a retrospective study","volume":"268","author":"Froelich","year":"2011","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.tripleo.2011.04.020_bib92","series-title":"The neural crest","author":"Le Douarin","year":"1999"},{"key":"10.1016\/j.tripleo.2011.04.020_bib93","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1601-0825.2007.01402.x","article-title":"Disparate osteogenic response of mandible and iliac crest bone marrow stromal cells to pamidronate","volume":"14","author":"Stefanik","year":"2008","journal-title":"Oral Dis"},{"key":"10.1016\/j.tripleo.2011.04.020_bib94","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1601-0825.2010.01778.x","article-title":"Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment","volume":"17","author":"Wehrhan","year":"2011","journal-title":"Oral Dis"},{"key":"10.1016\/j.tripleo.2011.04.020_bib95","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1387\/ijdb.052115dk","article-title":"Msx1 and Msx2 have shared essential functions in neural crest but may be dispensable in epidermis and axis formation in Xenopus","volume":"50","author":"Khadka","year":"2006","journal-title":"Int J Dev Biol"},{"key":"10.1016\/j.tripleo.2011.04.020_bib96","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1242\/dev.037440","article-title":"Lrp6-mediated canonical Wnt signaling is required for lip formation and fusion","volume":"136","author":"Song","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.tripleo.2011.04.020_bib97","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s12026-009-8093-x","article-title":"The emerging field of osteoimmunology","volume":"45","author":"Mensah","year":"2009","journal-title":"Immunol Res"},{"key":"10.1016\/j.tripleo.2011.04.020_bib98","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0006-291X(91)91360-O","article-title":"Effect of parathyroid hormone on release of interleukin 1 and interleukin 6 from cultured mouse osteoblastic cells","volume":"179","author":"Li","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.tripleo.2011.04.020_bib99","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1210\/endo-129-3-1513","article-title":"The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro","volume":"129","author":"Littlewood","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.tripleo.2011.04.020_bib100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11914-010-0008-1","article-title":"The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy","volume":"8","author":"Kumar","year":"2010","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.tripleo.2011.04.020_bib101","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.joms.2007.11.035","article-title":"Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy","volume":"66","author":"Sedghizadeh","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.04.020_bib102","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","article-title":"Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?","volume":"41","author":"Reid","year":"2007","journal-title":"Bone"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210411002721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210411002721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T01:03:42Z","timestamp":1638234222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079210411002721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":102,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1079210411002721"],"URL":"https:\/\/doi.org\/10.1016\/j.tripleo.2011.04.020","relation":{},"ISSN":["1079-2104"],"issn-type":[{"value":"1079-2104","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}